Covered recipient · General Payments record
SUNALI PATEL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$905.97
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $347.86 | 11 |
| Education | $76.05 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $284.37 | 19 |
| Galderma Laboratories, L.P. | $139.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.55 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107811957 | CMS |
| ABBVIE INC. | $8.45 | 03/19/2024 | Education | Undisputed | 01/23/2026 | 1107811961 | CMS |
| ABBVIE INC. | $8.45 | 03/19/2024 | Education | Undisputed | 01/23/2026 | 1107811965 | CMS |
| ABBVIE INC. | $8.45 | 03/19/2024 | Education | Undisputed | 01/23/2026 | 1107811970 | CMS |
| ABBVIE INC. | $8.45 | 03/19/2024 | Education | Undisputed | 01/23/2026 | 1107811974 | CMS |
| ABBVIE INC. | $32.54 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107811979 | CMS |
| ABBVIE INC. | $8.45 | 04/19/2024 | Education | Undisputed | 01/23/2026 | 1107811983 | CMS |
| ABBVIE INC. | $8.45 | 04/19/2024 | Education | Undisputed | 01/23/2026 | 1107811987 | CMS |
| ABBVIE INC. | $8.45 | 04/19/2024 | Education | Undisputed | 01/23/2026 | 1107811992 | CMS |
| ABBVIE INC. | $8.45 | 04/19/2024 | Education | Undisputed | 01/23/2026 | 1107811996 | CMS |
| ABBVIE INC. | $8.45 | 04/19/2024 | Education | Undisputed | 01/23/2026 | 1107812000 | CMS |
| ABBVIE INC. | $22.38 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107812004 | CMS |
| ABBVIE INC. | $22.42 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107812009 | CMS |
| ABBVIE INC. | $9.01 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107812013 | CMS |
| ABBVIE INC. | $34.50 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107812018 | CMS |
| ABBVIE INC. | $30.76 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107812022 | CMS |
| ABBVIE INC. | $8.61 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107812026 | CMS |
| ABBVIE INC. | $12.78 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107812031 | CMS |
| ABBVIE INC. | $28.77 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107812035 | CMS |
| Galderma Laboratories, L.P. | $139.54 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145382490 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.